Digital Standards Aim to Modernize Quality Assurance without Compromising Confidence

Laboratory scientists, regulatory reviewers, and other professionals responsible for ensuring the quality of medicines are increasingly moving toward digitized workflows. Digital-first tools promise greater efficiency, stronger data integrity, and faster decision-making, yet the reality is its use remains fragmented in many quality environments. Manual steps, such as retyping quality testing instructions, transferring data between systems, or translating standards into formats digital tools can use, continue to slow progress and introduce risk.

As the pharmaceutical industry and quality control labs move toward more connected, data-driven operations, the challenge is not whether to adopt digital technologies, but how to do so while upholding the rigor and confidence that patient safety demands. Emerging digital quality standards offer a path forward by embedding established quality expectations for medicines directly into digital environments, helping quality professionals and regulators work more efficiently without compromising control or traceability.1

At its core, digitizing quality workflows is about enabling experts to focus on science rather than systems. Making it faster and easier for quality control laboratories and regulators to adopt the tools that help ensure the quality of medicines as workflows evolve is essential. Digital standards are poised to play a critical role by complementing and aligning traditional compendial expectations and modern laboratory technologies to strengthen confidence as more data, methods, and decisions become digital.

Why Digital Standards Matter in Practice

Digital standards are digitally structured, and machine-readable quality standards. They are designed to carry forward the same science-based rigor as traditional standards in formats that integrate seamlessly into digital workflows.2 For experts in quality control labs, this means fewer manual handoffs, less rework, faster method deployment, and clearer traceability across the lifecycle of a method or dataset. For scientists, as well as regulators and reviewers, digitally structured standards can support more consistent standards interpretation and reduced ambiguity on standards implementation to reinforce confidence as regulatory submissions and inspections rely increasingly on digital data.

In quality control labs, the practical impact of digital standards can be significant. When standards integrate into digital workflows, teams spend less time translating text into systems and more time applying scientific judgment. Risk mitigation and traceability are enhanced through electronic capture of steps, version control, and clearer references. Technology transfer can be accelerated through standardized digital workflows and “digital twin” reference materials that help reduce variability across sites and organizations. Automation and advanced analytics become more accessible, freeing resources and supporting continuous improvement. Digital reference standards also avoid some of the inherent limitations of physical materials, such as degradation, logistical or shipping constraints, and environmental impacts associated with solvents or hazardous substances.

From Technology Adoption to Quality Enablement

As quality specialists know, technology alone is not the solution to laboratory digitization. As digital tools evolve rapidly, quality still depends on consistent, trusted standards that can be applied across platforms and organizations. This is where collaboration becomes essential. Enabling adoption of new technologies while upholding quality requires close alignment among method developers, manufacturers, technology providers, and regulators. Digital standards can act as shared, trusted building blocks, helping organizations scale digital workflows with confidence while keeping quality and traceability front and center—from early development of new medicines through commercial manufacturing and delivery.

Progress in developing and implementing digital standards that can make the biggest difference depends on engaging with real-world use cases and learning how new digital technologies perform in operational laboratories. Collaborative development helps ensure that digital standards are practical, fit for purpose, and aligned with regulatory expectations. When industry and regulators contribute early input to these emerging standards, uncertainty may be reduced and adoption may become more feasible, even for organizations with limited resources navigating complex digital transformations.

Quality as a Shared Responsibility in a Digital Era

At the U.S. Pharmacopeia (USP), quality is the foundation of a range of solutions being developed to facilitate quality control lab digitization. USP is advancing digital standards and related tools to support innovation while preserving the trust placed in compendial standards worldwide. 3 By evolving reference standards and documentary methods into validated, digital-first, machine-readable formats, USP is working to integrate quality expectations directly into digitized workflows and to build clear compendial pathways for adopting and scaling emerging technologies—from advanced laboratory informatics to nuclear magnetic resonance analysis software, artificial intelligence, and advanced analytics.

Updates to the USP–NF quality standards framework formally acknowledge that reference standards may be provided as either physical materials or digital data, which is an important step toward reducing uncertainty and strengthening regulatory confidence as digital approaches mature.4 Complementary tools, such as automated software solutions that embed compendial references into analytical workflows, illustrate how digital standards can be applied in practice.

Ultimately, ensuring the quality of medicines in a digital era is a shared responsibility. Digital standards will succeed not because they are new, but because they are trusted, science-based, and developed in collaboration with the community they serve to maximize the value they bring to that community. By working together to align innovation with quality, industry, laboratory scientists, regulators, and other professionals can harness the efficiencies of digital transformation while ensuring quality remains the shared foundation connecting innovation, regulation, and patient care.

References

1. Emerging Standards. USP. Accessed June 9, 2026. https://www.usp.org/get-involved/emerging-standards-platform
2. Quality Matters. USP. Published March 24, 2026. https://qualitymatters.usp.org/digital-standards-supporting-people-who-protect-quality-medicines-digital-world
3. Digital Standards. USP. Accessed June 9, 2026. https://www.usp.org/digital-standards
4. United States Pharmacopeia-National Formulary. USP. Published December 1, 2025. https://www.uspnf.com/

About USP

The U.S. Pharmacopeia (USP) is a private, non-profit, scientific organization that develops standards and solutions that help build trust in the supply of quality medicines. Through its rigorous science, USP sets public quality standards that help protect patient safety and improve the health of people around the world. Engage with USP on digital standards by visiting USP’s digital standards web page.